C260-2393 Screening compound: 4-({1-[(2-chlorophenyl)methyl]-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl}methyl)-N-cyclopentylcyclohexane-1-carboxamide

C260-2393 Screening compound: 4-({1-[(2-chlorophenyl)methyl]-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl}methyl)-N-cyclopentylcyclohexane-1-carboxamide
C260-2393 Screening compound: 4-({1-[(2-chlorophenyl)methyl]-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl}methyl)-N-cyclopentylcyclohexane-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C260-2393
4-({1-[(2-chlorophenyl)methyl]-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl}methyl)-N-cyclopentylcyclohexane-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C260-2393

Molecular Formula

C28H32ClN3O3 (C28 H32 ClN3 O3)

Compound Name

4-({1-[(2-chlorophenyl)methyl]-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl}methyl)-N-cyclopentylcyclohexane-1-carboxamide

IUPAC name

4-({1-[(2-chlorophenyl)methyl]-24-dioxo-1234-tetrahydroquinazolin-3-yl}methyl)-N-cyclopentylcyclohexane-1-carboxamide

SMILES

O=C(C1CCC(CN(C(c(cccc2)c2N2Cc(cccc3)c3Cl)=O)C2=O)CC1)NC1CCCC1

InChI

InChI=1S/C28H32ClN3O3/c29-24-11-5-1-7-21(24)18-31-25-12-6-4-10-23(25)27(34)32(28(31)35)17-19-13-15-20(16-14-19)26(33)30-22-8-2-3-9-22/h1,4-7,10-12,19-20,22H,2-3,8-9,13-18H2,(H,30,33)

InChI Key

NIHLRLOSFTVDKB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD05718177

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

494.03

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.547

Distribution Coefficient, logD

5.547

Water Solubility, LogSw

-5.87

Polar Surface Area

55.964

Acid Dissociation Constant (pKa)

15.70

Base Dissociation Constant (pKb)

0.89

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

46.40

C260-2393 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C260-2393 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C260-2393?
Check Price and Availability of C260-2393, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C260-2393 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C260-2393
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C260-2393
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C260-2393 available by request